Viridian Therapeutics Files 8-K on Officer/Director Changes
Ticker: VRDN · Form: 8-K · Filed: Jun 24, 2025 · CIK: 1590750
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes, filing
TL;DR
Viridian Therapeutics filed an 8-K detailing leadership changes and upcoming votes.
AI Summary
Viridian Therapeutics, Inc. filed an 8-K on June 24, 2025, reporting events as of June 20, 2025. The filing indicates changes related to the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements. It also covers the submission of matters to a vote of security holders and financial statements and exhibits.
Why It Matters
This filing signals potential shifts in the company's leadership and governance structure, which could impact strategic direction and operational execution.
Risk Assessment
Risk Level: medium — Changes in directors or officers can indicate internal shifts or strategic realignments that may affect the company's future performance.
Key Players & Entities
- Viridian Therapeutics, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- June 20, 2025 (date) — Earliest event reported date
- June 24, 2025 (date) — Filing date
FAQ
What specific changes were made regarding directors or officers?
The filing indicates "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers" as an item of disclosure, but the specific names and details of these changes are not provided in the summary information.
Were any new compensatory arrangements disclosed for officers?
Yes, the filing lists "Compensatory Arrangements of Certain Officers" as an item of disclosure, suggesting that information regarding such arrangements is included.
Did Viridian Therapeutics submit any matters to a vote of security holders?
Yes, the filing explicitly states "Submission of Matters to a Vote of Security Holders" as an item reported.
What financial information was included in this filing?
The filing includes "Financial Statements and Exhibits" as an item, indicating that financial data and related documents are part of the report.
What is the former name of Viridian Therapeutics, Inc.?
The filing mentions that the former company name was "MIRAGEN THERAPEUTICS, INC." and prior to that "SIGNAL GENETICS, INC.", with name changes occurring on February 13, 2017, and July 10, 2014, respectively.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 24, 2025 regarding Viridian Therapeutics, Inc.\DE (VRDN).